Search
Showing results for "1"
News & Events
$3.4 million funding boost supercharges fight against RSVNational research led by the Wesfarmers Centre of Vaccines and Infectious Diseases, based at The Kids Research Institute Australia, has secured more than $3.4 million to assess the epidemiology of respiratory syncytial virus (RSV) throughout the country and optimise Australia’s immunisation strategy.
The CMVictory Study aims to learn more about the safety and effectiveness of a potential CMV vaccine.
Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@thekids.org.au PAEDS Paediatric Active
Understanding how families engage with screen technologies and how it may influence child development
This project aims to investigate the impact of a non-severe burn injury on children's health for life.
Virtual Scientific Launch Day: Wednesday 1 December 2021 (Australia) Time: 7am Australian WST/ 10am Australian EDST / 12pm NZ DST North America:
News & Events
Gifted pump proves a life changer for familyOliver Bowman is too young to understand the enormity of having type 1 diabetes but his young parents Brooke and Aidan know all too well the reality of having a child with a chronic disease.
Research
Improving lung health of Aboriginal children hospitalised with chest infections – Aboriginal Children’s Excellent (ACE) Lung Health StudyThe ACE project is led by Dr Pamela Laird and aims to improve post-hospitalisation follow-up of Indigenous children hospitalised with acute lower respiratory tract infections.
Research
Racial discrimination and child and adolescent health in longitudinal studies: A systematic reviewThis review emphasises the need to gain evidence for the mechanisms linking early racism exposure to adverse health outcomes in later life
Research
Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapyTime-critical transcriptional events in the immune microenvironment are important for response to immune checkpoint blockade (ICB), yet these events are difficult to characterise and remain incompletely understood. Here, we present whole tumor RNA sequencing data in the context of treatment with ICB in murine models of AB1 mesothelioma and Renca renal cell cancer.